Clinical trials recruiting in Ballarat, Australia
10
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 2Phase 2 3Phase 3 5Not applicable 2
Conditions recruiting in Ballarat, Australia
Recruiting trials in Ballarat, Australia
- A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
- A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination Therapy in Subjects With HR-Positive/HER2-Negative Cancer
- EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
- National Robotics-Assisted Radical Prostatectomy Database
- PRIORITY-CONNECT 2 Trial
- Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- Working Out M0 Bipolar Androgen Therapy
Common questions
How many clinical trials are recruiting in Ballarat, Australia?
10 recruiting trials have at least one study site in Ballarat, Australia.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.